Glaucoma is a complex and multifactorial neurodegenerative disorder primarily characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, leading to irreversible visual ...

Among last year's top gainers was Axon Enterprise (NASDAQ: AXON), which makes tech-based software and hardware for the law enforcement and public safety industries. Axon has been a winning stock ...

Axon Enterprise, Inc. AXON is poised to benefit from persistent strength across its end markets, a healthy demand environment, acquired assets and focus on operational efficiency. The company ...

In flies defective for axonal transport of mitochondria, the authors report the upregulation of one subunit, the beta subunit, of the heterotrimeric eIF2 complex via mass spectroscopy proteome ...

In fact, Axon stock plunged by more than 80% from its 2004 peak and didn't reach a new all-time high until 2015. However, management kept executing during this period, growing revenue by more than ...

Axonotmesis indicates a loss of axon continuity, though the endoneural tube is preserved. This structural injury results in wallerian degeneration. Severe crush or traction injuries can produce ...

“Based on several preclinical efficacy studies and what is known about the central role of calpain-2 in the process of axonal degeneration, we believe AMX0114 has the potential to be a treatment ...

Axon Enterprise has threatened to move its hub out of north Scottsdale after a likely public referendum to kill its $1.3 billion, mixed-use headquarters expansion. The maker of Taser ...

a neuronally enriched nicotinamide adenine dinucleotide hydrolase that functions as a significant axon-intrinsic metabolic sensor and central driver of axon degeneration. It also develops therapies ...